DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 09 · Volume 72 · 1994 DOI: 10.1055/s-008-40508

Review Article

  • 330
    Boneu, B:

    Low Molecular Weight Heparin Therapy: Is Monitoring Needed?

    • Original Article

  • 335
    Moor, Elisabeth; Hamsten, Anders; Blombäck, Margareta; Herzfeld, Istvan; Wiman, Björn; Rydén, Lars:

    Haemostatic Factors and Inhibitors and Coronary Artery Bypass Grafting: Preoperative Alterations and Relations to Graft Occlusion

  • 343
    Alessandri, Cesare; Basili, Stefania; Violi, Francesco; Ferroni, Patrizia; Gazzaniga, Pier Paolo; Cordova, Corrado; C.O.B.H. Group:

    Hypercoagulability State in Patients with Chronic Obstructive Pulmonary Disease

  • 347
    Azar, Aida J; Deckers, Jaap W; Rosendaal, Frits R; van Bergen, Paul F M M; van der Meer, Felix J M; Jonker, Jan J C; Briëf, Ernest:

    Assessment of Therapeutic Quality Control in a Long-Term Anticoagulant Trial in Post-Myocardial Infarction Patients

  • 352
    De Stefano, V; Leone, G; Mastrangelo, S; Tripodi, A; Rodeghiero, F; Castaman, G; Barbui, T; Finazzi, G; Bizzi, B; Mannucci, P M:

    Clinical Manifestations and Management of Inherited Thrombophilia: Retrospective Analysis and Follow-up after Diagnosis of 238 Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S

  • 359
    Varon, D; Schulman, S; Dardik, R; Barzilai, A; Bashari, D; Martinowitz, U:

    High Versus Ultra-high Purity Factor VIII Concentrate Therapy: Prospective Evaluation of Immunological and Clinical Parameters in HIV Seronegative and Seropositive Hemophiliacs

  • 363
    Vijaya Mohan Rao, L; Zivelin, Ariella; Iturbe, Ignacio; Rapaport, Samuel I:

    Antibody-Induced Acute Factor X Deficiency: Clinical Manifestations and Properties of the Antibody

  • 372
    Meissner, Mark H; Manzo, Richard A; Bergelin, Robert O; Eugene Strandness, D:

    Venous Diameter and Compliance after Deep Venous Thrombosis

  • 377
    Biemond, Bart J; Levi, Marcel; Nurmohanned, Michael T; Büller, Harry R; ten Cate, Jan W:

    Additive Effect of the Combined Administration of Low Molecular Weight Heparin and Recombinant Hirudin on Thrombus Growth in a Rabbit Jugular Vein Thrombosis Model

  • 381
    Berry, Christopher N; Girardot, Christine; Lecoffreo, Catherine; Lunven, Catherine:

    Effects of the Synthetic Thrombin Inhibitor Argatroban on Fibrin- or Clot-Incorporated Thrombin: Comparison with Heparin and Recombinant Hirudin

  • 387
    Gallistl, Siegfried; Muntean, Wolfgang:

    Thrombin-Hirudin Complex Formation, Thrombin-Antithrombin III Complex Formation, and Thrombin Generation after Intrinsic Activation of Plasma

  • 393
    Yamazaki, Masahide; Asakura, Hidesaku; Aoshima, Keiji; Saito, Masanori; Jokaji, Hiroshi; Uotani, Chika; Kumabashiri, Ichir; Morishita, Eriko; Ikeda, Takayuki; Matsuda, Tamotsu:

    Effects of DX-9065a, an Orally Active, Newly Synthesized and Specific Inhibitor of Factor Xa, against Experimental Disseminated Intravascular Coagulation in Rats

  • 397
    von dem Borne, Peter A Kr; Koppelman, Stefan J; Bouma, Bonno N; Meijers, Joost C M:

    Surface Independent Factor XI Activation by Thrombin in the Presence of High Molecular Weight Kininogen

  • 403
    Schulman, S; Varon, D; Keller, N; Gitel, S; Martinowitz, U:

    Monoclonal Purified F VIII for Continuous Infusion: Stability, Microbiological Safety and Clinical Experience

  • 408
    Meijer-Huizinga, Fenny; Mertens, Koen; van Mourik, Jan A:

    Isolation and Characterization of Single-Chain Protein S

  • 415
    Arnljots, Björn; Bergqvist, David; Dahlbäck, Björn:

    Inhibition of Microarterial Thrombosis by Activated Protein C in a Rabbit Model

  • 421
    Ono, Mayumi; Nawa, Katsuhiko; Marumoto, Yasumasa:

    Antithrombotic Effects of Recombinant Human Soluble Thrombomodulin in a Rat Model of Vascular Shunt Thrombosis

  • 426
    Kitchen, S; Walker, I D; Woods, T A L; Preston, F E:

    Thromboplastin Related Differences in the Determination of International Normalised Ratio: A Cause for Concern?

  • 430
    Mola, Marco; Mannucci, Pier Mannuccio; Pini, Marlo; Prandoni, Paolo; Gurewich, Victor:

    A Pilot Study of Pro-Urokinase in the Treatment of Deep Vein Thrombosis

  • 434
    Bruckert, E; Ankri, A; Glral, P; Turpin, G:

    Relation between Plasminogen Activator Inhibitor-1 and Hepatic Enzyme Concentrations in Hyperlipidemic Patients

  • 438
    Lu, He; Du Buit, Charles; Soria, Jeannette; Touchot, Bernard; Chollet, Bernard; Commin, Pierre L; Conseiller, Christian; Echter, Ernest; Soria, Claudine:

    Postoperative Hemostasis and Fibrinolysis in Patients Undergoing Cardiopulmonary Bypass with or without Aprotinin Therapy

  • 444
    Simsek, S; Admiraal, L G; Modderman, P W; van der Schoot, C E; von dem Borne, A E G Kr:

    Identification of a Homozygous Single Base Pair Deletion in the Gene Coding for the Human Platelet Glycoprotein Ibα Causing Bernard-Soulier Syndrome

  • 450
    Maugeri, Norma; Evangelista, Virgilio; Celardo, Antonio; Dell’Elba, Giuseppe; Martelli, Nicola; Piccardoni, Paola; de Gaetano, Glovanni; Cerletti, Chiara:

    Polymorphonuclear Leukocyte-Platelet Interaction: Role of P-Selectin in Thromboxane B2 and Leukotriene C4 Cooperative Synthesis

  • 457
    Hemmer, Christoph J; Bierhaus, A; Riedesel, J v; Gabat, S; Liliensiek, B; Pitronik, P; Lin, J; Grauer, A; Amiral, J; Ziegler, R; Schieffer, S; Kern, P; Seitz, R; Egbring, R; Dietrich, M; Nawroth, P P:

    Elevated Thrombomodulin Plasma Levels as a Result of Endothelial Involvement in Plasmodium falciparum Malaria

  • 465
    Bangalore, Neelesh; Drohan, William N; Orthner, Carolyn L:

    High Affinity Binding Sites for Activated Protein C and Protein C on Cultured Human Umbilical Vein Endothelial Cells

  • 477
    Markwardt, F:

    Inventory of Coagulation Inhibitors from Animals Feeding on Blood

  • 481
    Simioni, Paolo; Prandoni, Paolo; Girolami, Antonio:

    Patients with AT III, Protein C or Protein S Defects Show no Associated Hereditary APC-Resistance

  • 482
    Bannon, P G; Dawes, J; Dean, R T:

    Malformin A Prevents IL-1 Induced Endothelial Changes by Inhibition of Protein Synthesis

  • 483
    Schoppmann, Axel; Weber, Alfred; Hondl, Felix; Linnau, Yendra:

    Factor VIII Concentrate: What is “High Purity”?

  • 484
    Fabris, Fabrizio; Luzzatto, Guido; Randi, Maria Luigia; Cella, Giuseppe:

    Beta-Thromboglobulin (βtg) and Platelet Factor 4 (PF4) in Patients with Myeloproliferative Diseases

  • 485
    Bellucci, Sylvia:

    Beta-Thromboglobulin and Platelet Factor 4 in Patients with Myeloproliferative Diseases - Reply

  • 486
    Meyer-Luerssen, D:

    Questions Concerning the New Recommended Mean Normal Prothrombin Time (MNPT) to Calculate the International Normalized Ratio (INR)

  • 487
    van den Besselaar, A M H P:

    Arguments for the Recommended Mean Normal Prothrombin Time to Calculate the International Normalized Ratio - Rebuttal

  • 488
    Smith, Michael; Kortmann, Cas:

    Rebuttal of the Article of Bounameaux et al

  • 489
    Bounameaux, H; de Moerloose, P; Perrier, A; Reber, G:

    Reply to the Rebuttal of Smith and Kortmann

    • Scientific and Standardization Committee Communications

  • 475
    Peake, Ian; Tuddenham, Edward:

    A Standard Nomenclature for Factor VIII and Factor IX Gene Mutations and Associated Amino Acid Alterations